Becton, Dickinson and Company (BDXB) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Instruments & Supplies industria. La empresa tiene su sede en Franklin Lakes, NJ, United States. El CEO actual es Thomas E. Polen Jr..
BDXB tiene fecha de IPO 2020-05-21, 77,000 empleados a tiempo completo, cotiza en el NYSE, una capitalización de mercado de $13.69B.
Becton, Dickinson and Company is a global leader in medical technology, developing, manufacturing, and distributing a comprehensive portfolio of medical supplies, devices, laboratory equipment, and diagnostic products. The company serves healthcare institutions, physicians, life science researchers, clinical laboratories, and the pharmaceutical industry through three primary business segments: BD Medical, which provides IV catheters, infusion systems, syringes, diabetes care products, and medication management solutions; BD Life Sciences, which offers specimen collection, microbiology automation, molecular testing systems, and cell analysis instruments; and BD Interventional, which specializes in surgical products, grafts, and critical care devices. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, Becton Dickinson operates worldwide to advance patient care and clinical outcomes across multiple healthcare settings.
